A program with a moderated panel discussion format that focuses on the evolving cell & gene therapy ecosystem in and around Philadelphia. The discussion will include how cell and gene therapy is different than traditional pharmaceutical manufacturing in terms of operations/logistics, facility design, quality, and regulatory considerations. We will also discuss what makes this geographical area such a potent ecosystem, attracting new companies and organizations over the past   2-3 years, as well as keeping companies here and fostering their growth. Four dynamic presenters representing different owners’ considerations will provide their insight and answer questions posed by the attendees.


Marti DiPietro – R&D Operations PM at Spark Therapeutics

Dunni Odumosu – Senior Director, Regulatory Affairs Gene Therapy at BridgeBio

Allison Montalvo – Executive Director, Project Management and Clinical Supply at Tmunity Therapeutics

Emilie Pelletier – Senior Director Process Engineering at Iovance Biotherapeutics